MYGN
Myriad Genetics Inc
4.00$
+0.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 14.0% | 20.4% | 21.2% | 23.5% | 23.8% | 23.6% | 32.0% | 28.6% | 29.8% | 31.4% | 30.1% | 30.1% | |
| 86.0% | 79.6% | 78.8% | 76.5% | 76.2% | 76.4% | 68.0% | 71.4% | 70.2% | 68.6% | 69.9% | 69.9% | |
| 8.7% | 10.4% | 9.5% | 10.2% | 9.5% | 10.1% | 14.5% | 11.9% | 12.6% | 11.8% | 13.5% | 13.0% | |
| 42.0% | – | – | – | – | 65.4% | 91.1% | 77.9% | 36.5% | 37.7% | 32.9% | 31.1% | |
| 50.7% | 61.1% | 58.0% | 70.5% | 59.8% | 75.5% | 117.3% | 99.0% | 88.5% | 87.8% | 80.4% | 78.2% | |
| 35.3% | 18.6% | 20.7% | 6.0% | 16.4% | 0.9% | -35.0% | -27.6% | -18.2% | -19.2% | -10.5% | -8.2% | |
| 0.0% | 0.0% | 0.0% | 0.8% | 0.4% | 1.4% | 1.9% | 1.0% | 0.5% | 0.4% | 0.3% | 1.3% | |
| 35.7% | 18.7% | 21.1% | 5.0% | 16.1% | 0.9% | -50.9% | -8.3% | -20.7% | -34.8% | -14.7% | -47.9% | |
| 13.1% | 7.6% | 5.2% | 2.6% | -1.7% | -0.5% | -10.8% | -4.3% | -4.2% | 0.1% | 0.5% | -3.5% | |
| 22.6% | 11.1% | 15.8% | 2.4% | 17.9% | 0.5% | -40.2% | -3.9% | -16.5% | -35.0% | -15.2% | -44.4% | |
| 37.0% | 22.1% | 24.7% | 12.4% | 23.9% | 10.0% | -22.2% | 1.8% | -12.5% | -26.2% | -7.1% | -40.1% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.